|
MAT2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.197530E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.779110E-03 |
| Normal-vs-Stage2 |
4.436400E-03 |
| Normal-vs-Stage3 |
8.220000E-04 |
| Normal-vs-Stage4 |
5.626800E-04 |
| Stage1-vs-Stage2 |
2.719800E-01 |
| Stage1-vs-Stage3 |
4.259200E-01 |
| Stage1-vs-Stage4 |
2.539200E-01 |
| Stage2-vs-Stage3 |
6.415800E-01 |
| Stage2-vs-Stage4 |
8.632600E-01 |
| Stage3-vs-Stage4 |
7.150000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.057200E-03 |
| Normal-vs-AfricanAmerican |
8.779700E-03 |
| Normal-vs-Asian |
4.682300E-02 |
| Caucasian-vs-AfricanAmerican |
7.199200E-01 |
| Caucasian-vs-Asian |
5.655600E-01 |
| AfricanAmerican-vs-Asian |
4.674600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.822890E-03 |
| Normal-vs-Female |
1.799380E-03 |
| Male-vs-Female |
7.026200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.676300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.923700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.06319999999094E-05 |
| Normal-vs-Age(81-100Yrs) |
1.742650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.165000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.921700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.547600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.663700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.758600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.914400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.651200E-01 |
| Classical-VS-Follicular |
1.87990000000138E-06 |
| Classical-VS-Other |
8.810500E-02 |
| Classical-VS-Normal |
3.504200E-02 |
| Tall-VS-Follicular |
3.124400E-02 |
| Tall-VS-Other |
3.344800E-01 |
| Tall-VS-Normal |
3.660000E-02 |
| Follicular-VS-Other |
9.076800E-01 |
| Follicular-VS-Normal |
1.00609999997836E-06 |
| Other-VS-Normal |
1.343910E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.44810000000051E-05 |
| Normal-vs-N1 |
2.023500E-03 |
| N0-vs-N1 |
8.954400E-01 |
|
|
